CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Option exercise | +15,000 | $0.41 | $6K | 15,000 |
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Option exercise | +10,000 | $11.00 | $110K | 25,000 |
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Sale | −2,300 | $53.77 | $124K | 22,700 |
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Sale | −5,655 | $54.45 | $308K | 17,045 |
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Sale | −6,872 | $55.55 | $382K | 10,173 |
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Sale | −9,573 | $56.60 | $542K | 600 |
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Sale | −600 | $57.17 | $34K | 0 |
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −15,000 | 59,425 | ||
| 2021-02-17 | O'Neill Vincent Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −10,000 | 21,047 | ||
| 2021-02-16 | Yocca Frank Chief Scientific Officer | Sale | −1,300 | $55.88 | $73K | 87,097 |
| 2021-02-16 | Yocca Frank Chief Scientific Officer | Sale | −6,805 | $56.49 | $384K | 80,292 |
| 2021-02-16 | Yocca Frank Chief Scientific Officer | Sale | −1,137 | $57.71 | $66K | 79,155 |
| 2021-02-16 | Yocca Frank Chief Scientific Officer | Sale | −2,886 | $58.54 | $169K | 76,269 |
| 2021-02-16 | Yocca Frank Chief Scientific Officer | Sale | −500 | $59.46 | $30K | 75,769 |
| 2021-02-16 | Yocca Frank Chief Scientific Officer | Sale | −1,772 | $60.43 | $107K | 73,997 |
| 2021-02-16 | Yocca Frank Chief Scientific Officer | Sale | −600 | $61.20 | $37K | 73,397 |
| 2021-02-01 | Steinhart Richard I Chief Financial Officer | Option exercise | +3,750 | $5.55 | $21K | 5,250 |
| 2021-02-01 | Steinhart Richard I Chief Financial Officer | Sale | −3,750 | $48.15 | $181K | 1,500 |
| 2021-02-01 | Steinhart Richard I Chief Financial Officer | Option exercise · Stock Option | −3,750 | 80,148 | ||
| 2021-01-25 | Yocca Frank Chief Scientific Officer | Option exercise | +15,000 | $0.41 | $6K | 103,397 |
Page 24 of 27 · 521 trades